Avadel Pharmaceuticals plc promoted Gregory Divis to be executive vice president and COO, a newly created role at the Dublin-based company.

Divis joined the pharmaceuticals company in January 2017 as chief commercial officer.

He will be responsible for the company's U.S. and European-based operations, including supply chain, business development and commercial operations.